TLIS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jul 2024 @ 19:25):
Our systems believe the stock currently is undervalued by 0.08% compare to its pairs and should correct upwards.

Stats
Dagens volum	7 971
Gjennomsnittsvolum	7 606
Markedsverdi	15.68M
EPS	$-7.15 ( Q1 \| 2024-05-08 )
Neste inntjeningsdato	( $0 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.270 (Sector) 42.63 (Industry) 0
ATR14	$0.202 (2.35%)

AEMD -4.56%

AFIB -12.68%

AHCO -1.65%

AHPI 0.00%

ALGN -0.70%

ANIK 2.11%

APEN 0.00%

APYX 0.75%

ARAY -4.67%

ATEC -5.07%

AXDX -1.71%

AXGN 4.97%

AXNX 0.05%

AZYO 2.05%

BBLG -1.36%

BIOL 20.00%

BJDX -0.01%

BMRA -1.07%

BRKR -2.71%

BSGM -2.88%

BWAY -3.46%

CERS -1.45%

CFMS 0.44%

CLPT 1.50%

CODX -0.80%

CSII 0.15%

CTKB -0.16%

CTSO 7.04%

CUTR 0.00%

CVRX -4.88%

DCTH -2.03%

DXCM -1.68%

DYNT -20.26%

EAR -4.10%

ECOR -2.33%

EDAP -2.94%

ESTA -5.06%

FONR 0.02%

HJLI -1.98%

HSDT -1.26%

HSKA 0.00%

HYPR 4.71%

IART -1.24%

ICAD -1.54%

ICCM -1.32%

IINN -11.59%

INGN -2.21%

INMD -1.53%

IRIX -4.28%

IRMD -1.48%

IRTC -2.39%

ISO 0.00%

ITMR 0.00%

KIDS -1.84%

LHDX 0.00%

LIVN -0.27%

LNSR -0.37%

LUCD -4.74%

LUNG -2.37%

MASS -7.18%

MDGS 10.28%

MOTS -7.82%

MOVE 5.78%

MSON 0.00%

NAOV 4.91%

NARI 3.24%

NMRD 33.33%

NNOX -1.36%

NPCE -2.18%

NTUS 0.00%

NURO -1.62%

NUVA -2.24%

NUWE -6.62%

NVCN 0.00%

NVNO -2.67%

OBLN -5.86%

OFIX -2.26%

OM -3.90%

PACB -7.69%

PAVM 4.44%

PETV -32.69%

PODD -2.38%

PRCT 0.64%

PROF 2.12%

QIPT -2.17%

QTRX -4.35%

RCEL -2.27%

RPID 2.80%

RSLS 1.36%

RWLK 6.07%

RXST -2.79%

SGHT -6.07%

SIBN -2.05%

SIEN -18.69%

SILK -0.13%

SINT -3.33%

SOLY 0.00%

SRDX -0.19%

SRGA 0.00%

SRTS -7.13%

SWAV 0.00%

TBIO 6.85%

TCMD -3.69%

TELA 0.11%

THMO -14.29%

TIVC -1.22%

TLIS -2.22%

TMCI -1.95%

TMDI 0.00%

TMDX 0.19%

TNDM -3.60%

TNON 14.02%

UFPT 4.97%

VERO -2.75%

VIVE 0.00%

VMD -2.14%

VRAY 0.00%

VREX -2.85%

VVOS 3.60%

XAIR 5.53%

XENT 0.00%

ZIMV -0.52%

Insider Trading

Date	Person	Action	Amount	type
2023-08-01	Lukowiak Andrew A	Buy	30 575	Stock option (right to buy)
2023-08-01	Lukowiak Andrew A	Buy	0
2023-07-17	Markovich Rebecca	Buy	13 071	Stock option (right to buy)
2023-06-09	Baker Bros. Advisors Lp	Buy	23 685	Non- Qualified Stock Option (right to buy)
2023-06-09	Scott Randal W.	Buy	95 000	Stock option (right to buy)

INSIDER POWER
77.04
Last 91 transactions
Buy: 54 998 856 \| Sell: 42 065 023

Korrelasjon (AI algo v.1.1b): Undervalued: 0.08% $8.61 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Talis Biomedical Korrelasjon

10 Mest positive korrelasjoner
JAN	0.817
RVMD	0.816
ADSE	0.803
CRTO	0.803

10 Mest negative korrelasjoner
UONE	-0.844
ENSC	-0.844
LFLY	-0.839
UONEK	-0.838
HWBK	-0.833
HFFG	-0.825
BRKL	-0.825
CNTG	-0.821
VGSH	-0.818
QLGN	-0.817

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Talis Biomedical Økonomi

Annual	2023
Omsetning:	$412 000
Bruttogevinst:	$-4.70M (-1 141.50 %)
EPS:	$-34.12

FY	2023
Omsetning:	$412 000
Bruttogevinst:	$-4.70M (-1 141.50 %)
EPS:	$-34.12

FY	2022
Omsetning:	$3.65M
Bruttogevinst:	$-4.74M (-129.76 %)
EPS:	$-62.45

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-8.48

Financial Reports:

No articles found.

Talis Biomedical Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Talis Biomedical

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.